US FDA extends review of Ascendis Pharma's therapy for children with dwarfism-March 2024-www.financetom.com

US FDA extends review of Ascendis Pharma's therapy for children with dwarfism

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA extends review of Ascendis Pharma's therapy for children with dwarfism

Nov 25, 2025 3:45 PM

Nov 25 (Reuters) - The U.S. Food and Drug Administration

on Tuesday extended its review of Ascendis Pharma's ( ASND )

therapy for children with a rare genetic disorder that causes

dwarfism, the company said.

The health regulator extended its review by 3 months to

February 28, 2026.

Previous page： Google agrees $36 million fine for anti-competitive deals with Australia telcos Next page： Equifax Insider Sold Shares Worth $518,200, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Equifax Insider Sold Shares Worth $518,200, According to a Recent SEC Filing

May 26, 2025

04:42 PM EDT, 05/08/2025 (MT Newswires) -- John W Gamble Jr, Executive Vice President, CFO & COO, on May 06, 2025, sold 2,000 shares in Equifax ( EFX ) for $518,200. Following the Form 4 filing with the SEC, Gamble has control over a total of 65,176 common shares of the company, with 65,176 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/33185/000122520825004851/xslF345X05/doc4.xml...

Ptc Insider Sold Shares Worth $318,080, According to a Recent SEC Filing

May 26, 2025

04:42 PM EDT, 05/08/2025 (MT Newswires) -- Aaron C Von Staats, Executive Vice President, General Counsel and Secretary, on May 07, 2025, sold 1,988 shares in Ptc (PTC) for $318,080. Following the Form 4 filing with the SEC, Von Staats has control over a total of 17,731 common shares of the company, with 17,731 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/857005/000165495425005287/xslF345X05/section16.xml...

Sezzle Insider Sold Shares Worth $1,350,000, According to a Recent SEC Filing

May 26, 2025

04:42 PM EDT, 05/08/2025 (MT Newswires) -- Paul Paradis, Director & President, on May 08, 2025, sold 18,000 shares in Sezzle ( SEZL ) for $1,350,000. Following the Form 4 filing with the SEC, Paradis has control over a total of 1,398,648 common shares of the company, with 578,382 shares held directly and 820,266 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1662991/000166299125000088/xslF345X05/wk-form4_1746735386.xml ...